MedPath

VEPESID

VEPESID

Approved
DIN Number

00616192

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

Cheplapharm Arzneimittel Gmbh

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00616192
AIG Number0114567001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ETOPOSIDEActive
Strength: 50 MG
Monograph: ETOPOSIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.